Medical Marijuana, Inc. subsidiary HempMeds® Brasil is helping to expand our understanding of neurological disorders with its sponsorship of the 8th ABN-RJ/ANERJ Congress.
HempMeds® Brasil, part of the Medical Marijuana, Inc. family of companies is continuing its mission of safe and reliable cannabinoid access with its sponsorship of an important neurology event in Brazil this weekend. The company is dedicated to arming doctors and patients in Brazil with the research they need to choose the best treatment option for their individual needs.
The 8th Brazilian Academy of Neurology/Association of Neurology of the State of Rio de Janeiro (ABN-RJ/ANERJ) Congress Workshops will bring together noted neurologists and others specializing in the various fields of neurology to share the latest developments in neurological research and discuss the implications it may hold in the understanding and treatment of neurological disorders.
“We are proud to sponsor this neurological-focused event that we believe will focus attention toward improving the quality of treatment for people with neurological disorders,” said Medical Marijuana, Inc.’s CEO Dr. Stuart Titus. “With its neuroprotective, anti-oxidative and anti-inflammatory effects, cannabidiol (CBD) is making new inroads into neurological research. Given potential neuro-regenerative effects, CBD further holds the potential to revolutionize neurological medicine.”
The 8th ABN-RJ/ANERJ Congress is planned for September 28-30 at the Windsor Barra Convention Center in Rio De Janeiro, Brazil. Over the three day event, attendees will be able to sit in on dozens of lectures, research presentations, and panel discussions exploring recent discoveries in neurology and their implications on the diagnosis and treatment of related disorders. At the event, HempMeds® Brasil will have a booth, where attendees can stop by and learn more about RSHO™ CBD oil products.
HempMeds® Brasil has long been dedicated to the furthering of medical research – especially when it comes to CBD. Earlier in the year, the company hosted doctors events in Rio de Janeiro and Sao Paulo. These events, filled to capacity, invited doctors from across Brazil to meet with company executives, learn more about the benefits of a CBD treatment option, and discuss best practices when prescribing CBD.
In 2014, the company became the first to legally ship cannabis-based products to Brazil when its flagship RSHO™ CBD oil products were authorized for import by ANVISA following a passionate court case and concentrated public support. Now, doctors in the country can prescribe CBD oil products from HempMeds® Brasil for any medical condition that they feel their patient can benefit from CBD. In the past, these conditions have included epilepsy, pain, cancer, Parkinson’s, Alzheimer’s, migraines, and more.
Patients and doctors in Brazil who are interested in learning more about CBD and its therapeutic uses should visit HempMeds® Brasil online. The company’s website is a complete source for information on CBD in Brazil, including step by step instructions for accessing these exciting products. Visit HempMeds® Brasil online HERE.
Discover more about HempMeds® Brasil and the rest of the Medical Marijuana, Inc. portfolio of companies on our news feed.